DE3777611D1 - Lysozyme hydrochlorid und dikaliumglycyrrhizinat enthaltende loesung. - Google Patents

Lysozyme hydrochlorid und dikaliumglycyrrhizinat enthaltende loesung.

Info

Publication number
DE3777611D1
DE3777611D1 DE8787118175T DE3777611T DE3777611D1 DE 3777611 D1 DE3777611 D1 DE 3777611D1 DE 8787118175 T DE8787118175 T DE 8787118175T DE 3777611 T DE3777611 T DE 3777611T DE 3777611 D1 DE3777611 D1 DE 3777611D1
Authority
DE
Germany
Prior art keywords
hydrochloride
glycyrrhizinate
lysocyme
dikalium
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787118175T
Other languages
English (en)
Inventor
Yoshio Kogure
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE3777611D1 publication Critical patent/DE3777611D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
DE8787118175T 1986-12-19 1987-12-08 Lysozyme hydrochlorid und dikaliumglycyrrhizinat enthaltende loesung. Expired - Fee Related DE3777611D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61303163A JPH085800B2 (ja) 1986-12-19 1986-12-19 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤

Publications (1)

Publication Number Publication Date
DE3777611D1 true DE3777611D1 (de) 1992-04-23

Family

ID=17917640

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787118175T Expired - Fee Related DE3777611D1 (de) 1986-12-19 1987-12-08 Lysozyme hydrochlorid und dikaliumglycyrrhizinat enthaltende loesung.

Country Status (10)

Country Link
US (1) US4961927A (de)
EP (1) EP0275457B1 (de)
JP (1) JPH085800B2 (de)
KR (1) KR910005885B1 (de)
AT (1) ATE73670T1 (de)
DE (1) DE3777611D1 (de)
ES (1) ES2036566T3 (de)
GR (1) GR3004119T3 (de)
PH (1) PH24628A (de)
PT (1) PT86400B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3887494T2 (de) * 1987-11-13 1994-05-19 Smithkline Beecham Farma Ein Calcitonin sowie ein Glycyrrhizinat als Absorptionsförderer enthaltende Arzneimittel.
JP2700465B2 (ja) * 1988-05-09 1998-01-21 関西酵素株式会社 塩化リゾチーム配合トイレタリー製品
IT8920486A0 (it) * 1989-05-12 1989-05-12 Isf Spa Composizioni farmaceutiche.
JPH06199648A (ja) * 1993-01-08 1994-07-19 Kao Corp 可溶化型化粧料
US5482710A (en) * 1993-07-30 1996-01-09 Chesebrough-Pond'usa Co., Division Of Conopco, Inc. Cosmetic composition for treatment of pimples and redness
CA2232855C (en) 1997-04-10 2007-10-09 Roche Consumer Health (Worldwide) Sa Pharmaceutical formulation
IT1291366B1 (it) * 1997-05-14 1999-01-07 Angelini Ricerche Spa Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale
US6432424B1 (en) 2000-06-29 2002-08-13 Johnson & Johnson Consumer Companies, Inc. Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid
US6649176B1 (en) 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
US6630175B1 (en) * 2000-06-29 2003-10-07 Johnson & Johnson Consumer Companies, Inc. Method of reducing eye irritation
US6372791B1 (en) 2000-06-29 2002-04-16 Johnson & Johnson Consumer Companies, Inc. Method of promoting skin cell metabolism
US7678389B1 (en) * 2004-06-16 2010-03-16 Scott Cordray Treatment of optic and otic inflammation
US20100080790A1 (en) * 2005-07-13 2010-04-01 University Of South Carolina Sterilization using high-pressure carbon dioxide
US20070264362A1 (en) * 2006-05-11 2007-11-15 Nina Yoshpe Method and composition for treating ear inflammation caused by dry ear
WO2008109397A2 (en) * 2007-03-02 2008-09-12 Saint Simeon Lda Novel ophthalmic compositions containing human recombinant lysozyme and use thereof for treating eye conditions and as contact lens solutions
JP5274826B2 (ja) * 2007-12-12 2013-08-28 サンスター株式会社 口腔用組成物
IT1401153B1 (it) * 2010-07-28 2013-07-12 Neova Technologies B V Formulazioni di lisozima gelificato
US8758836B2 (en) 2011-09-09 2014-06-24 Nina S. YOSHPE Method and formulation for treating dry ear inflammation with cortisone
WO2017209721A1 (en) 2016-06-02 2017-12-07 Alemdar Eda A drug derived from enzymes present in the human saliva for use in preventing corneal clouding or cataract formation
CN109718246A (zh) * 2019-02-19 2019-05-07 刘宝林 一种鼻腔清洗液

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB843135A (en) * 1957-07-16 1960-08-04 Biorex Laboratories Ltd Glycyrrhetinic acid salts
US3419471A (en) * 1965-04-19 1968-12-31 Eisai Co Ltd Preparation of albumin-free lysozyme
FR2037000A1 (en) * 1969-04-30 1970-12-31 Pluripharm Non allergic lysozyme chlorhydrate prepn
JPS49310A (de) * 1972-04-14 1974-01-05
JPS56110609A (en) * 1980-02-06 1981-09-01 Lion Corp Composition for oral cavity
JPS5746922A (en) * 1980-09-05 1982-03-17 Ss Pharmaceut Co Ltd Stable aqueous lysozyme solution
GB2122893B (en) * 1982-06-30 1985-06-26 Biorex Laboratories Ltd Glycyrrhetinic acid compositions
AU553789B2 (en) * 1982-06-30 1986-07-24 Biorex Laboratories Ltd. Glycyrrhetinic acid derivatives in cream compositions

Also Published As

Publication number Publication date
GR3004119T3 (de) 1993-03-31
PH24628A (en) 1990-08-17
EP0275457B1 (de) 1992-03-18
ATE73670T1 (de) 1992-04-15
JPS63156728A (ja) 1988-06-29
PT86400B (pt) 1990-11-20
EP0275457A3 (en) 1988-09-07
KR910005885B1 (ko) 1991-08-06
PT86400A (en) 1988-01-01
ES2036566T3 (es) 1993-06-01
JPH085800B2 (ja) 1996-01-24
KR880007059A (ko) 1988-08-26
EP0275457A2 (de) 1988-07-27
US4961927A (en) 1990-10-09

Similar Documents

Publication Publication Date Title
ATE73670T1 (de) Lysozyme hydrochlorid und dikaliumglycyrrhizinat enthaltende loesung.
MA19639A1 (fr) Procede de preparation de derives de l'acide cis, endo-2-azabicyclo- (3,3,0) -octane-3- carboxylique et d'agents contenant ces derives
IL97538A0 (en) Liposomes containing an aminoglycoside salt and their preparation
BR8601404A (pt) Composicao de alvejamento aquosa,estavel,espessada,de baixo ph
OA09227A (fr) "Sels de céphalosporine, mélanges contenant ces sels et procédé de préparation du sel d'addition d'acide sulfurique".
KR900011887A (ko) 효소 및 효소 안정화 시스템을 함유하는 액체 세제 조성물
PT86233A (fr) Procede de preparation d:une variant de l:hirudine
PL238572A1 (en) Pesticide and method of manufacture of novel substituted diamides of hydroxymalonic acids
ATE38097T1 (de) Stabilisierte, ein enzymkonjugat enthaltende zusammensetzung.
IL110566A0 (en) Stable aqueous solutions of hybrid alpha-interferon
OA07904A (fr) Composition nutritive de l'acide alpha-cétois un de ses sels.
DE3665320D1 (en) Stabilization of peroxidase activity in solution
RO90109A (ro) Procedeu de preparare a unor saruri de alchilsulfoniu ale n-fosfonometilglicinei
FR2619098B1 (fr) Procede de purification de saumures concentrees d'halogenures alcalins
ES551363A0 (es) Procedimiento para fabricar carbonato de sodio anhidro denso
FR2601674B1 (fr) Procede de preparation d'une solution aqueuse du sel de sodium de la methionine
ES8603434A1 (es) Un procedimiento para la produccion del 1, 2, 4-triazolilpropanol
MA20222A1 (fr) Procede pour la preparation d'une solution aqueuse de chlorure de sodium, et procede de fabrication de bicarbonate de sodium.
BE892931A (fr) Purification d'une solution aqueuse de carbonate d'ammonium
UA6327A1 (uk) Спосіб одержання похідних галоідпірідіна
DE3362523D1 (en) Optically active imidazolylpropanol compounds, and their production and use
ATE130616T1 (de) Stabiles hexahydrat von etoposid-4'-phosphat- dinatriumsalz.
FR2534475B1 (fr) Procede de concentration d'une solution antibiotique b-lactame aqueuse
ES2001620A6 (es) Procedimiento para la obtencion de una solucion a base de luprostiol
PT856511E (pt) Indometacina calcica penta-hidratada e sua preparacao

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee